Literature DB >> 18945266

Fast FSR variable selection with applications to clinical trials.

Dennis D Boos1, Leonard A Stefanski, Yujun Wu.   

Abstract

A new version of the false selection rate variable selection method of Wu, Boos, and Stefanski (2007, Journal of the American Statistical Association 102, 235-243) is developed that requires no simulation. This version allows the tuning parameter in forward selection to be estimated simply by hand calculation from a summary table of output even for situations where the number of explanatory variables is larger than the sample size. Because of the computational simplicity, the method can be used in permutation tests and inside bagging loops for improved prediction. Illustration is provided in clinical trials for linear regression, logistic regression, and Cox proportional hazards regression.

Entities:  

Mesh:

Year:  2008        PMID: 18945266      PMCID: PMC2748177          DOI: 10.1111/j.1541-0420.2008.01127.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  3 in total

1.  A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team.

Authors:  S M Hammer; D A Katzenstein; M D Hughes; H Gundacker; R T Schooley; R H Haubrich; W K Henry; M M Lederman; J P Phair; M Niu; M S Hirsch; T C Merigan
Journal:  N Engl J Med       Date:  1996-10-10       Impact factor: 91.245

2.  Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes.

Authors: 
Journal:  N Engl J Med       Date:  1998-08-13       Impact factor: 91.245

3.  Covariate adjustment for two-sample treatment comparisons in randomized clinical trials: a principled yet flexible approach.

Authors:  Anastasios A Tsiatis; Marie Davidian; Min Zhang; Xiaomin Lu
Journal:  Stat Med       Date:  2008-10-15       Impact factor: 2.373

  3 in total
  8 in total

1.  Saphenous vein graft failure after coronary artery bypass surgery: insights from PREVENT IV.

Authors:  Connie N Hess; Renato D Lopes; C Michael Gibson; Rebecca Hager; Daniel M Wojdyla; Brian R Englum; Michael J Mack; Robert M Califf; Nicholas T Kouchoukos; Eric D Peterson; John H Alexander
Journal:  Circulation       Date:  2014-09-26       Impact factor: 29.690

2.  Variable selection for covariate-adjusted semiparametric inference in randomized clinical trials.

Authors:  Shuai Yuan; Hao Helen Zhang; Marie Davidian
Journal:  Stat Med       Date:  2012-06-26       Impact factor: 2.373

3.  Selection of nonlinear interactions by a forward stepwise algorithm: Application to identifying environmental chemical mixtures affecting health outcomes.

Authors:  Naveen N Narisetty; Bhramar Mukherjee; Yin-Hsiu Chen; Richard Gonzalez; John D Meeker
Journal:  Stat Med       Date:  2018-12-26       Impact factor: 2.373

4.  FSR Methods for Second-Order Regression Models.

Authors:  Hugh B Crews; Dennis D Boos; Leonard A Stefanski
Journal:  Comput Stat Data Anal       Date:  2011-06-01       Impact factor: 1.681

5.  A hierarchical integrative group least absolute shrinkage and selection operator for analyzing environmental mixtures.

Authors:  Jonathan Boss; Alexander Rix; Yin-Hsiu Chen; Naveen N Narisetty; Zhenke Wu; Kelly K Ferguson; Thomas F McElrath; John D Meeker; Bhramar Mukherjee
Journal:  Environmetrics       Date:  2021-07-30       Impact factor: 1.527

6.  Edifoligide and long-term outcomes after coronary artery bypass grafting: PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) 5-year results.

Authors:  Renato D Lopes; Judson B Williams; Rajendra H Mehta; Eric M Reyes; Gail E Hafley; Keith B Allen; Michael J Mack; Eric D Peterson; Robert A Harrington; C Michael Gibson; Robert M Califf; Nicholas T Kouchoukos; T Bruce Ferguson; Todd J Lorenz; John H Alexander
Journal:  Am Heart J       Date:  2012-09       Impact factor: 4.749

7.  Frequency and Predictors of Internal Mammary Artery Graft Failure and Subsequent Clinical Outcomes: Insights From the Project of Ex-vivo Vein Graft Engineering via Transfection (PREVENT) IV Trial.

Authors:  Ralf E Harskamp; John H Alexander; T Bruce Ferguson; Rebecca Hager; Michael J Mack; Brian Englum; Daniel Wojdyla; Phillip J Schulte; Nicholas T Kouchoukos; Robbert J de Winter; C Michael Gibson; Eric D Peterson; Robert A Harrington; Peter K Smith; Renato D Lopes
Journal:  Circulation       Date:  2015-12-08       Impact factor: 29.690

8.  Ascertainment, classification, and impact of neoplasm detection during prolonged treatment with dual antiplatelet therapy with prasugrel vs. clopidogrel following acute coronary syndrome.

Authors:  Matthew T Roe; Derek D Cyr; Debra Eckart; Phillip J Schulte; Michael A Morse; Kimberly L Blackwell; Neal E Ready; S Yousuf Zafar; Anne W Beaven; John H Strickler; Jane E Onken; Kenneth J Winters; Lisa Houterloot; Dmitry Zamoryakhin; Stephen D Wiviott; Harvey D White; Dorairaj Prabhakaran; Keith A A Fox; Paul W Armstrong; E Magnus Ohman
Journal:  Eur Heart J       Date:  2015-12-05       Impact factor: 29.983

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.